← Leaderboards
Dmitri Simberg
University Of California, San Diego
$8,108,683
Attributed
$9,707,586
Total exposure
11
Grants
10
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.2M · FY2009–25$2M$1.5M$1M$500K$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$9,707,586 · 11
By mechanism
R01$8,568,998 · 5
R21$1,113,588 · 4
R13$25,000 · 2
Top collaborators
- Irina V Balyasnikova4 shared
- Tomoko Hayashi3 shared
- Thomas Anchordoquy2 shared
- Keith B Neeves1 shared
Most similar at University Of California, San Diego
Same institution · by research overlap
- Mark H Tuszynski$42,403,260
- Mark H Ellisman$83,284,775
- Steffanie A Strathdee$53,933,577
- Michael Karin$60,628,305
- Gregory Aarons$22,775,310
Others in their field
Top investigators on “In Vivo”
- David Heimbrook · Leidos Biomedical Research, Inc.$371,850,582
- Leonard Freedman · Leidos Biomedical Research, Inc.$304,459,298
- Dennis R. Burton · Scripps Research Institute$212,708,174
- Mark S Klempner · Tufts Medical Center$128,021,180
- Florian Krammer · Icahn School Of Medicine At Mount Sinai$104,723,856
- David M. Margolis · University Of Texas Sw Med Ctr/Dallas$98,374,200
Research focus
In VivoNovel StrategiesDrug Delivery SystemsIn VitroPharmaceutical PreparationsNanoparticleCellsDoseUptakeAntibodiesBloodDesignLipidsLiposomesLeukocytesBaseCell MembraneImmuneImageNanoformulationPathway InteractionsComplementInnovationNanomedicine
Grant awards (28)
Fluorescent Indocarbocyanine PEGylated Lipid Nanoparticles for Understanding and Overcoming Barriers to Drug Delivery in Invasive Glioblastoma$529,375
R01 · FY2025 · CA · contact PI
Reducing Off-Target Accumulation of Chemotherapeutic Nanomedicines$375,134
R01 · FY2025 · CA
Hemostatic erythrocytes for acute non-compressible hemorrhage$234,000
R21 · FY2025 · HL · contact PI
The Alternative Complement Pathway and Hemocompatibility of Nanosurfaces$539,005
R01 · FY2024 · AI · contact PI
Fluorescent Indocarbocyanine PEGylated Lipid Nanoparticles for Understanding and Overcoming Barriers to Drug Delivery in Invasive Glioblastoma$533,757
R01 · FY2024 · CA · contact PI
The Alternative Complement Pathway and Hemocompatibility of Nanosurfaces$633,860
R01 · FY2023 · AI · contact PI
Fluorescent Indocarbocyanine PEGylated Lipid Nanoparticles for Understanding and Overcoming Barriers to Drug Delivery in Invasive Glioblastoma$563,302
R01 · FY2023 · CA · contact PI
Mechanisms and Barriers in Nanomedicine-2023$15,000
R13 · FY2023 · EB · contact PI
The Alternative Complement Pathway and Hemocompatibility of Nanosurfaces$633,860
R01 · FY2022 · AI · contact PI
Fluorescent Indocarbocyanine PEGylated Lipid Nanoparticles for Understanding and Overcoming Barriers to Drug Delivery in Invasive Glioblastoma$588,673
R01 · FY2022 · CA · contact PI
The Alternative Complement Pathway and Hemocompatibility of Nanosurfaces$554,555
R01 · FY2021 · AI · contact PI
The Alternative Complement Pathway and Hemocompatibility of Nanosurfaces$491,764
R01 · FY2020 · AI · contact PI
Painted erythrocyte carriers for therapy of acute myeloid leukemia$352,151
R01 · FY2020 · CA · contact PI
The alternative complement pathway and hemocompatibility of nanosurfaces$343,881
R01 · FY2019 · EB · contact PI
Painted erythrocyte carriers for therapy of acute myeloid leukemia$341,585
R01 · FY2019 · CA · contact PI
Painted erythrocyte carriers for therapy of acute myeloid leukemia$352,151
R01 · FY2018 · CA · contact PI
The alternative complement pathway and hemocompatibility of nanosurfaces$343,881
R01 · FY2018 · EB · contact PI
Painted erythrocyte carriers for therapy of acute myeloid leukemia$352,151
R01 · FY2017 · CA · contact PI
The alternative complement pathway and hemocompatibility of nanosurfaces$343,881
R01 · FY2017 · EB · contact PI
Painted erythrocyte carriers for therapy of acute myeloid leukemia$352,151
R01 · FY2016 · CA · contact PI
The alternative complement pathway and hemocompatibility of nanosurfaces$343,881
R01 · FY2016 · EB · contact PI
Mechanisms and barriers in nanomedicine$10,000
R13 · FY2016 · EB · contact PI
Photo-assisted targeting of immunotherapy to the bladder$163,073
R21 · FY2013 · CA · contact PI
Photo-assisted targeting of immunotherapy to the bladder$27,066
R21 · FY2013 · CA · contact PI
Photo-assisted targeting of immunotherapy to the bladder$168,426
R21 · FY2012 · CA · contact PI
Non-invasive sampling of DNA markers for pancreatic cancer screening$161,005
R21 · FY2012 · CA · contact PI
Isolation of rare circulating tumor cells from blood using microbubbles$196,769
R21 · FY2010 · CA · contact PI
Isolation of rare circulating tumor cells from blood using microbubbles$163,249
R21 · FY2009 · CA · contact PI